Neurobehavioral Impairment and CPAP Treatment Response in Mild-Moderate Obstructive Sleep Apnea

Conclusions:Patients with mild to moderate OSA have significant neurobehavioral morbidity. During“gold standard” treatment, normal function was not achieved, even with adequate device usage. CPAP efficacy for improving sleepiness and neuropsychological function in this milder end of the OSA spectrum may be poor, which may affect CPAP adherence. These findings suggest that there may be neurological changes related to OSA that do not respond to CPAP treatment, the etiology of which requires further investigation.Citation:Jackson ML, McEvoy RD, Banks S, Barnes M. Neurobehavioral impairment and CPAP treatment response in mild-moderate obstructive sleep apnea.J Clin Sleep Med. 2018;14(1):47–56.
Source: Journal of Clinical Sleep Medicine : JCSM - Category: Sleep Medicine Source Type: research